User menu

A Systematic Review of the Predictive Value of (18)FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification

Bibliographic reference Schollaert, Pascaline ; Crott, Ralph ; Bertrand, Claude ; D'Hondt, Lionel ; Vander Borght, Thierry ; et. al. A Systematic Review of the Predictive Value of (18)FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification. In: Journal of Gastrointestinal Surgery, Vol. 18, no. 5, p. 894-905 (2014)
Permanent URL http://hdl.handle.net/2078.1/142640
  1. Jemal Ahmedin, Bray Freddie, Center Melissa M., Ferlay Jacques, Ward Elizabeth, Forman David, Global cancer statistics, 10.3322/caac.20107
  2. Gebski Val, Burmeister Bryan, Smithers B Mark, Foo Kerwyn, Zalcberg John, Simes John, Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis, 10.1016/s1470-2045(07)70039-6
  3. van Hagen P., Hulshof M.C.C.M., van Lanschot J.J.B., Steyerberg E.W., Henegouwen M.I. van Berge, Wijnhoven B.P.L., Richel D.J., Nieuwenhuijzen G.A.P., Hospers G.A.P., Bonenkamp J.J., Cuesta M.A., Blaisse R.J.B., Busch O.R.C., ten Kate F.J.W., Creemers G.-J., Punt C.J.A., Plukker J.T.M., Verheul H.M.W., Bilgen E.J. Spillenaar, van Dekken H., van der Sangen M.J.C., Rozema T., Biermann K., Beukema J.C., Piet A.H.M., van Rij C.M., Reinders J.G., Tilanus H.W., van der Gaast A., Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer, 10.1056/nejmoa1112088
  4. Krause B. J., Herrmann K., Wieder H., zum Buschenfelde C. M., 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer, 10.2967/jnumed.108.057232
  5. Vallböhmer D., Hölscher Arnulf H., DeMeester S., DeMeester T., Salo J., Peters J., Lerut T., Swisher S. G., Schröder W., Bollschweiler E., Hofstetter W., A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal Cancer : , 10.1097/sla.0b013e3181fb8dde
  6. Zhu Aizhi, Lee Daniel, Shim Hyunsuk, Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response, 10.1053/j.seminoncol.2010.11.012
  7. Juweid Malik E., Cheson Bruce D., Positron-Emission Tomography and Assessment of Cancer Therapy, 10.1056/nejmra050276
  8. Wong R., Walker-Dilks C., Raifu A., Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer, 10.1016/j.clon.2011.09.006
  9. Smyth Elizabeth C, Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies, 10.3748/wjg.v17.i46.5059
  10. Chua Sue, Dickson John, Groves Ashley M., PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma, 10.1007/s00259-011-1858-1
  11. Kwee Robert M., Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of18F FDG PET: A Systematic Review, 10.1148/radiol.09091324
  12. Esteves Fabio P., Schuster David M., Halkar Raghuveer K., Gastrointestinal Tract Malignancies and Positron Emission Tomography: An Overview, 10.1053/j.semnuclmed.2005.12.002
  13. Suttie S.A., Welch A.E., Park K.G.M., Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma, 10.1016/j.ejso.2009.01.012
  14. Wong Wai Lup, Chambers R. Jane, Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review, 10.1007/s00261-007-9241-1
  15. Malik V., Lucey J. A., Duffy G. J., Wilson L., McNamara L., Keogan M., Gillham C., Reynolds J. V., Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus, 10.2967/jnumed.110.079566
  16. Mamede Marcelo, Abreu-e-Lima Paula, Oliva Maria Raquel, Nos?? V??nia, Mamon Harvey, Gerbaudo Victor H., FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer : Correlation With Histopathology Results, 10.1097/coc.0b013e31803993f8
  17. Monjazeb Arta Monir, Riedlinger Greg, Aklilu Mebea, Geisinger Kim R., Mishra Girish, Isom Scott, Clark Paige, Levine Edward A., Blackstock A. William, Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?, 10.1200/jco.2010.30.7702
  18. Port Jeffrey L., Lee Paul C., Korst Robert J., Liss Yaakov, Meherally Danish, Christos Paul, Mazumdar Madhu, Altorki Nasser K., Positron Emission Tomographic Scanning Predicts Survival After Induction Chemotherapy for Esophageal Carcinoma, 10.1016/j.athoracsur.2007.03.094
  19. Roedl Johannes B., Halpern Elkan F., Colen Rivka R., Sahani Dushyant V., Fischman Alan J., Blake Michael A., Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus, 10.1007/s11307-008-0169-9
  20. Roedl Johannes B., Harisinghani Mukesh G., Colen Rivka R., Fischman Alan J., Blake Michael A., Mathisen Douglas J., Mueller Peter R., Assessment of Treatment Response and Recurrence in Esophageal Carcinoma Based on Tumor Length and Standardized Uptake Value on Positron Emission Tomography–Computed Tomography, 10.1016/j.athoracsur.2008.05.019
  21. Korst Robert J., Kansler Amanda L., Port Jeffrey L., Lee Paul C., Kerem Yaniv, Altorki Nasser K., Downstaging of T or N Predicts Long-Term Survival After Preoperative Chemotherapy and Radical Resection for Esophageal Carcinoma, 10.1016/j.athoracsur.2006.03.072
  22. Higgins J. P T, Measuring inconsistency in meta-analyses, 10.1136/bmj.327.7414.557
  23. Borenstein Michael, Higgins Julian P. T., Meta-Analysis and Subgroups, 10.1007/s11121-013-0377-7
  24. Riley Richard D, Abrams Keith R, Sutton Alexander J, Lambert Paul C, Thompson John R, Bivariate random-effects meta-analysis and the estimation of between-study correlation, 10.1186/1471-2288-7-3
  25. Riley R. D., Abrams K. R., Lambert P. C., Sutton A. J., Thompson J. R., An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes, 10.1002/sim.2524
  26. Abdelsalam Mahmoud, Bazarbashi Shouki, Abouzied Moheieldin, Amin Tarek, Soudy Hussein, Rahal Mohamed, Darwish Alaa, Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial, 10.5144/1658-3876.2010.179
  27. Brücher Björn L.D.M., Weber Wolfgang, Bauer Markus, Fink Ullrich, Avril Norbert, Stein Hubert J., Werner Martin, Zimmerman Frank, Siewert J. Rüdiger, Schwaiger Markus, Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography : , 10.1097/00000658-200103000-00002
  28. Downey Robert J., Akhurst Tim, Ilson David, Ginsberg Robert, Bains Manjit S., Gonen Mithat, Koong Heng, Gollub Marc, Minsky Bruce D., Zakowski Maureen, Turnbull Alan, Larson Steven M., Rusch Valerie, Whole Body18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial, 10.1200/jco.2003.04.013
  29. Duong Cuong P., Demitriou Helen, Weih LeAnn, Thompson Anne, Williams David, Thomas Robert J. S., Hicks Rodney J., Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer, 10.1007/s00259-005-0028-8
  30. Flamen P., Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer, 10.1093/annonc/mdf081
  31. Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, Tatsumi M, et al. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2008;136:205–212, 212 e201–203.
  32. Ilson DH, Minsky BD, Ku GY, Rusch V, Rizk N, Shah M, et al. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer 2011
  33. Ishihara R, Yamamoto S, Iishi H, Nagai K, Matui F, Kawada N, et al. Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy. Int. J. Clin. Oncol. 2011:1–8.
  34. Javeri Heta, Xiao Lianchun, Rohren Eric, Lee Jeffrey H., Liao Zhongxing, Hofstetter Wayne, Maru Dipen, Bhutani Manoop S., Swisher Stephen G., Macapinlac Homer, Wang Xuemei, Ajani Jaffer A., The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma, 10.1002/cncr.24604
  35. Jayachandran Priya, Pai Reetesh K., Quon Andrew, Graves Edward, Krakow Trevor E., La Trang, Loo Billy W., Koong Albert C., Chang Daniel T., Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer, 10.1016/j.ijrobp.2011.12.029
  36. Kauppi Juha T., Oksala Niku, Salo Jarmo A., Helin Heikki, Karhumäki Lauri, Kemppainen Jukka, Sihvo Eero I., Räsänen Jari V., Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by[18F]FDG-PET/CT, 10.3109/0284186x.2011.643822
  37. Kim Min Kyoung, Ryu Jin-Sook, Kim Sung-Bae, Ahn Jin Hee, Kim Soo Young, Park Seung-II, Kim Yong Hee, Song Ho Yong, Shin Ji Hoon, Jung Hwoon Yong, Lee Gin Hyug, Choi Kee Don, Cho Kyung-Ja, Kim Jong Hoon, Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy, 10.1016/j.ejca.2007.04.001
  38. Lordick Florian, Ott Katja, Krause Bernd-Joachim, Weber Wolfgang A, Becker Karen, Stein Hubert J, Lorenzen Sylvie, Schuster Tibor, Wieder Hinrich, Herrmann Ken, Bredenkamp Rainer, Höfler Heinz, Fink Ulrich, Peschel Christian, Schwaiger Markus, Siewert Jörg R, PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial, 10.1016/s1470-2045(07)70244-9
  39. Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, et al. Utility of response evaluation to neo-adjuvant chemotherapy by 18 F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery (USA) 2010;148:908–918.
  40. Swisher Stephen G., Maish Mary, Erasmus Jeremy J., Correa Arlene M., Ajani Jaffer A., Bresalier Robert, Komaki Ritsuko, Macapinlac Homer, Munden Reginald F., Putnam Joe B., Rice David, Smythe W.Roy, Vaporciyan Ara A., Walsh Garrett L., Wu Tsung T., Roth Jack A., Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer, 10.1016/j.athoracsur.2004.04.046
  41. Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058–3065.
  42. Wieder Hinrich A., Brücher Björn L.D.M., Zimmermann Frank, Becker Karen, Lordick Florian, Beer Ambros, Schwaiger Markus, Fink Ulrich, Siewert Jörg Rüdiger, Stein Hubert J., Weber Wolfgang A., Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment, 10.1200/jco.2004.07.122
  43. Wieder Hinrich A., Ott Katja, Lordick Florian, Becker Karen, Stahl Alexander, Herrmann Ken, Fink Ulrich, Siewert Jörg Rüdiger, Schwaiger Markus, Weber Wolfgang A., Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction, 10.1007/s00259-007-0521-3
  44. Yang Yanqin, Yang Zhiqiang, Han Anqin, Feng Rui, Ma Yidong, Kong Li, Sun Xindong, Zheng Jingsong, Yu Jinming, Prediction of the Outcome of Definitive Chemoradiation by Decrease in F-18 FDG Uptake in Nonsurgical Esophageal Squamous Cell Cancer : , 10.1097/rlu.0b013e318219b0c0
  45. Meyer zum Buschenfelde C., Herrmann K., Schuster T., Geinitz H., Langer R., Becker K., Ott K., Ebert M., Zimmermann F., Friess H., Schwaiger M., Peschel C., Lordick F., Krause B. J., 18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial, 10.2967/jnumed.110.085803
  46. Vallböhmer Daniel, Hölscher Arnulf H., Dietlein Markus, Bollschweiler Elfriede, Baldus Stephan E., Mönig Stefan P., Metzger Ralf, Schicha Harald, Schmidt Matthias, [18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer : , 10.1097/sla.0b013e3181bc9c0d
  47. Lorenzen Sylvie, Panzram Ben, Keller Gisela, Lordick Florian, Herrmann Ken, Becker Karin, Langer Ruppert, Schwaiger Markus, Siewert Jorg Rudiger, Ott Katja, Association of the VEGF 936C>T Polymorphism with FDG Uptake, Clinical, Histopathological, and Metabolic Response in Patients with Adenocarcinomas of the Esophagogastric Junction, 10.1007/s11307-010-0330-0
  48. Makino Tomoki, Doki Yuichiro, Miyata Hiroshi, Yasuda Takushi, Yamasaki Makoto, Fujiwara Yoshiyuki, Takiguchi Shuji, Higuchi Ichiro, Hatazawa Jun, Monden Morito, Use of 18F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma, 10.1016/j.surg.2008.06.026
  49. Murthy Santosh B., Patnana Srikrishna V., Xiao Lianchun, Rohren Eric, Hofstetter Wayne L., Swisher Stephen G., Liao Zhongxing, Lee Jeffrey H., Bhutani Manoop S., Macapinalac Homer A., Wang Xuemei, Ajani Jaffer A., The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma, 10.1159/000319938
  50. Ott Katja, Weber Wolfgang A., Lordick Florian, Becker Karen, Busch Raymonde, Herrmann Ken, Wieder Hinrich, Fink Ulrich, Schwaiger Markus, Siewert Jörg-Rüdiger, Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction, 10.1200/jco.2006.06.7801
  51. Patnana Srikrishna V., Murthy Santosh B., Xiao Lianchun, Rohren Eric, Hofstetter Wayne L., Swisher Stephen G., Liao Zhongxing, Lee Jeffrey H., Bhutani Manoop S., Macapinlac Homer A., Wang Xuemei, Ajani Jaffer A., Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography, 10.1002/cncr.25431
  52. Siewert Joerg R., Lordick Florian, Ott Katja, Stein Hubert J., Weber Wolfgang A., Becker Karen, Peschel Christian, Fink Ulrich, Schwaiger Markus, Induction Chemotherapy in Barrett Cancer : Influence on Surgical Risk and Outcome, 10.1097/sla.0b013e318155a7d1
  53. Swisher Stephen G., Erasmus Jeremy, Maish Mary, Correa Arlene M., Macapinlac Homer, Ajani Jaffer A., Cox James D., Komaki Ritsuko R., Hong David, Lee Hoon K., Putnam Joe B., Rice David C., Smythe W. Roy, Thai Linh, Vaporciyan Ara A., Walsh Garrett L., Wu Tsung-Teh, Roth Jack A., 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma, 10.1002/cncr.20585
  54. Whiting Penny F., Rutjes Anne W.S., Westwood Marie E., Mallett Susan, A systematic review classifies sources of bias and variation in diagnostic test accuracy studies, 10.1016/j.jclinepi.2013.05.014
  55. Whiting Penny, Rutjes Anne W.S., Reitsma Johannes B., Glas Afina S., Bossuyt Patrick M.M., Kleijnen Jos, Sources of Variation and Bias in Studies of Diagnostic Accuracy : A Systematic Review, 10.7326/0003-4819-140-3-200402030-00010
  56. Reid M. Carrington, Use of Methodological Standards in Diagnostic Test Research : Getting Better but Still Not Good, 10.1001/jama.1995.03530080061042
  57. Discussion, 10.1016/s0003-4975(99)00974-1
  58. Lijmer Jeroen G., Bossuyt Patrick M. M., Heisterkamp Siem H., Exploring sources of heterogeneity in systematic reviews of diagnostic tests, 10.1002/sim.1185
  59. Knottnerus J A., Evidence base of clinical diagnosis: Evaluation of diagnostic procedures, 10.1136/bmj.324.7335.477
  60. Cuenca Xavier, Hennequin Christophe, Hindié Elif, Rivera Sofia, Vercellino Laetitia, Baruch-Hennequin Valérie, Gornet Jean-Marc, Cattan Pierre, Chirica Mircea, Quéro Laurent, Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas, 10.1007/s00259-012-2325-3
  61. Zhu W, Xing L, Yue J, Sun X, Sun X, Zhao H, Yu J, Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis, 10.1259/bjr/29946900
  62. Juweid Malik E., Stroobants Sigrid, Hoekstra Otto S., Mottaghy Felix M., Dietlein Markus, Guermazi Ali, Wiseman Gregory A., Kostakoglu Lale, Scheidhauer Klemens, Buck Andreas, Naumann Ralph, Spaepen Karoline, Hicks Rodney J., Weber Wolfgang A., Reske Sven N., Schwaiger Markus, Schwartz Lawrence H., Zijlstra Josee M., Siegel Barry A., Cheson Bruce D., Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, 10.1200/jco.2006.08.2305